Predictive oncology stock.

A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. ... Predictive Oncology Inc. (POAI) Upgraded to Buy: What Does It Mean for the Stock?Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...

Predictive Oncology Inc (POAI) Stock Price & News - Google Finance Home POAI • NASDAQ Predictive Oncology Inc Follow Share $2.98 Nov 24, 5:45:00 PM GMT-5 · USD · NASDAQ · Disclaimer search...

Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Based on 79,403,893 shares of common stock issued and outstanding as of March 17, 2023, immediately following the Reverse Stock Split, the Company would have approximately 39,701,947 shares of common stock issued and outstanding (without giving effect to rounding for fractional shares) if the ratio for the Reverse Stock Split is one-for- …IDXX Vs POAI: Stock comparison by Artificial Intelligence. Which is a better buy? Make smart data-driven investment decisions and get unique insights. Start now and save 50% for the first 3 months. Ticker. Company. Your search produced no matches. We currently support US stocks and STOXX Europe 600 stocks.

Nov 17, 2023 · finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs.

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...

Nov 18, 2023 · Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares. Predictive Oncology Price Performance The stock […] Nov 17, 2023 · finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs. BJDX. Bluejay Diagnostics Inc. 3.04. -0.05. -1.62%. Get Predictive Oncology Inc (POAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top …2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest POAI News | Press Releases No...Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ...PREDICTIVE ONCOLOGY INC. 2915 Commers Drive, Suite 900. Eagan, Minnesota 55121. Telephone: (651) 389-4800 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

Plug Power: Implied upside in 2023 of 532%. The fourth and final growth stock expected to skyrocket in 2023 is hydrogen fuel-cell solutions company Plug Power ( PLUG 9.40%). If analyst Amit Dayal ...Oct 15, 2020 · The Predictive Oncology stock forecast is 4.3910063584427 USD for 2024 November 25, Monday; and 14.588 USD for 2028 November 25, Saturday with technical analysis. Predictive Oncology (POAI) stock price prediction is 4.3910063584427 USD. TipRanksJun 13, 2023 · Predictive Oncology (POAI) Predictive Oncology (NASDAQ: POAI) is the first of the best tech-based penny stocks to consider. Cancer research has come a long way and yet it still has so far to go ... With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

Mar 16, 2023 · EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ... Oncology Pharma Inc () Stock Market info Recommendations: Buy or sell Oncology Pharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oncology Pharma share forecasts, stock quote and buy / sell signals below.According to present data Oncology Pharma's ONPH shares and potentially its …

Nov 16, 2023 · PREDICTIVE ONCOLOGY INC. 2915 Commers Drive, Suite 900. Eagan, Minnesota 55121. Telephone: (651) 389-4800 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERS According to the issued ratings of 5 analysts in the last year, the consensus rating for Pyxis Oncology stock is Buy based on the current 5 buy ratings for PYXS. The average twelve-month price prediction for Pyxis Oncology is $8.33 with a high price target of $14.00 and a low price target of $4.00. Learn more on PYXS's analyst rating history.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that Thomas Bock, M.D., CEO of Notable Labs, will participate in a fireside chat at the JMP …Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ... Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average of $3.98. Predictive Oncology GAAP EPS of -$0.78, revenue of …

Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model.The company owns a biorepository of tumor samples, a lab and a good manufacturing practice ...

An increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end, which represents a positive change of 12%. Q2 2022 financial results. Predictive Oncology’s ...

Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors The estimated Net Worth of J Melville Engle is at least $103 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $99,663 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.Find the latest Ikena Oncology, Inc. (IKNA) stock quote, history, news and other vital information to help you with your stock trading and investing.David Johnson biography. David O. Johnson is Senior Vice President - Operations of Skyline Medical Inc. He was previously the Acting Chief Operating Officer for the Company since December 2011 and had been a consultant to medical device companies since October 2010.Big data and predictive analytics have immense potential to improve risk stratification, particularly in data-rich fields like oncology. This article reviews the literature published on use cases and challenges in applying predictive analytics to improve risk stratification in oncology. We characterized evidence-based use cases of predictive …Overview Press Releases Events & Presentations Financials & Filings Stock Quote & Chart Corporate Governance Contact Us Stock Quote (POAI) NASDAQ CM: POAI $3.17 Oct 2, 2023 4:00 PM EDT Change 0 (0.00%) Volume 0 Today's Open -- Previous Close $3.17 Today's High $3.20 Today's Low $3.07 52 Week High $13.88 52 Week Low $2.47 Stock ChartMar 16, 2023 · EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ... Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.

Charles Nuzum POAI stock SEC Form 4 insiders trading. Charles has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Charles bought 200,000 units of POAI stock worth $62,000 on 20 May 2022.200,000 units of POAI stock worth $62,000 on 20 May 2022.The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the stock fluctuated 6.77% from a day low at $2.84 to a day high of $3.03. The price has fallen in 7 of the last 10 days and is down by -10.68% for this period.Dec 22, 2021 · The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ... Instagram:https://instagram. nyseamerican pcg estreetsmart edge paper tradingpilots payfloating rate etf Latest company newsPredictive Oncology forms a strategic partnership that has the potential to revolutionize the field of radiation oncology. Digital newsroomLinks to …Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country. pacific premier bancorpappmail The estimated Net Worth of J Melville Engle is at least $987 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $984,422 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Dec 22, 2021 · The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ... how to invest in farmland Predictive Oncology Inc (POAI) stock is trading at $0.29 as of 3:29 PM on Tuesday, Apr 4, a loss of -$0.02, or -5.88% from the previous closing price of $0.31. The stock has traded between $0.28 and $0.31 so far today. Volume today is 336,440 compared to average volume of 417,533.POAI 2HR test Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and test Predictive Oncology, Inc. engages in …PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that ...